0001209191-20-024148.txt : 20200410 0001209191-20-024148.hdr.sgml : 20200410 20200410170907 ACCESSION NUMBER: 0001209191-20-024148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200408 FILED AS OF DATE: 20200410 DATE AS OF CHANGE: 20200410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kauffman Michael CENTRAL INDEX KEY: 0001364719 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 20787175 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 85 WELLS AVENUE, SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-08 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001364719 Kauffman Michael C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 1 1 0 0 Chief Executive Officer Common Stock 2020-04-09 4 M 0 10000 4.752 A 565122 D Common Stock 2020-04-09 4 S 0 10000 20.6404 D 555122 D Common Stock 2020-04-08 4 M 0 10000 4.752 A 766489 I By Spouse Common Stock 2020-04-08 4 S 0 10000 18.6115 D 756489 I By Spouse Stock Option (right to buy) 4.752 2020-04-09 4 M 0 10000 0.00 D 2023-09-02 Common Stock 10000 356061 D Stock Option (right to buy) 4.752 2020-04-08 4 M 0 10000 0.00 D 2023-09-02 Common Stock 10000 400303 I By Spouse These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.36 to $20.99, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.15 to $19.06, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. /s/Christopher B. Primiano, Attorney-in-Fact for Michael Kauffman 2020-04-10